BIO submits comments on IRA’s Medicare Drug Price Negotiation Program
On Friday, April 14, the Biotechnology Innovation Organization (BIO) weighed in on initial guidance regarding the Drug Price Negotiation Program (Negotiation Program) under the […]
BIO submits comments on IRA’s Medicare Drug Price Negotiation Program Read More »